279 related articles for article (PubMed ID: 2944579)
1. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
[TBL] [Abstract][Full Text] [Related]
2. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in normal and carcinomatous endometrium.
Neumannova M; Kauppila A; Vihko R
Obstet Gynecol; 1983 Feb; 61(2):181-8. PubMed ID: 6571973
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of estrogen and progestin receptors in ovarian cancer.
Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
[TBL] [Abstract][Full Text] [Related]
4. Cycle variation and distribution in the concentration of cytosol estrogen and progesterone receptors in the normal human uterus and myoma.
Ochiai K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):945-52. PubMed ID: 7240872
[TBL] [Abstract][Full Text] [Related]
5. Short-term effects of tamoxifen, medroxyprogesterone acetate, and their combination on receptor kinetics and 17 beta-hydroxysteroid dehydrogenase in human endometrium.
Neumannová M; Kauppila A; Kivinen S; Vihko R
Obstet Gynecol; 1985 Nov; 66(5):695-700. PubMed ID: 2997680
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone receptors in uterine sarcomas.
Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and progesterone receptor status in breast cancer in Kuwait female population.
Paszko Z; Omar YT; Nasralla MY; Jazzaf H; Bouzubar N; Temmim L; Padzik H
Neoplasma; 1993; 40(2):127-32. PubMed ID: 8350956
[TBL] [Abstract][Full Text] [Related]
8. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
Thorpe SM
Cancer Res; 1987 Apr; 47(7):1830-5. PubMed ID: 3545455
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen and progestin receptors as prognostic indicators in endometrial cancer. A review of the literature.
Kauppila A
Acta Oncol; 1989; 28(4):561-6. PubMed ID: 2675940
[TBL] [Abstract][Full Text] [Related]
10. Female sex steroid receptors in gynecological malignancies: clinical correlates.
Vihko R; Isotalo H; Kauppila A; Vierikko P
J Steroid Biochem; 1983 Jul; 19(1C):827-32. PubMed ID: 6887902
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome in endometrial cancer.
Kauppila A; Grönroos M; Nieminen U
Obstet Gynecol; 1982 Oct; 60(4):473-80. PubMed ID: 6214734
[TBL] [Abstract][Full Text] [Related]
12. Steroid receptors in normal, hyperplastic and malignant human endometria.
Vihko R; Jänne O; Kauppila A
Ann Clin Res; 1980 Oct; 12(5):208-15. PubMed ID: 7015983
[TBL] [Abstract][Full Text] [Related]
13. Cytosol estrogen and progestin receptor concentrations and 17 beta-hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue. Effects of hormonal treatment.
Kauppila A; Vierikko P; Isotalo H; Rönnberg L; Vihko R
Acta Obstet Gynecol Scand Suppl; 1984; 123():45-9. PubMed ID: 6093422
[TBL] [Abstract][Full Text] [Related]
14. [Endometrial cancer and steroid hormone receptors].
Nyholm HC
Ugeskr Laeger; 1990 Feb; 152(9):593-7. PubMed ID: 2408223
[TBL] [Abstract][Full Text] [Related]
15. [Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma--relation between clinical aspects and histopathology].
Gao YL
Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):451-4. PubMed ID: 3836850
[TBL] [Abstract][Full Text] [Related]
16. [Hormonal therapy of endometrial cancer].
Kato J
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1182-8. PubMed ID: 4057575
[TBL] [Abstract][Full Text] [Related]
17. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
18. Sex steroid receptors in endometrial cancer.
Chambers JT
Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700
[TBL] [Abstract][Full Text] [Related]
19. Correlation between estradiol-17 beta and progesterone cytosol receptor concentration, histologic differentiation and 3H-thymidine incorporation in endometrial carcinoma.
Lindahl B; Alm P; Borg A; Fernö M; Grundsell H; Johnsson JE; Norgren A; Tropé C
Anticancer Res; 1982; 2(4):203-7. PubMed ID: 7149649
[TBL] [Abstract][Full Text] [Related]
20. Influence of "nuclear" estrogen receptor content on prognosis of early stage carcinoma of the uterine body. A short-time follow-up.
Horvath G; Johnsson JE; Tropé C; Samuelsson L; Alm P; Olsson H
Neoplasma; 1990; 37(1):43-6. PubMed ID: 2320180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
